Israel Corporation reported $2.02B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Avient USD 847M 86M Mar/2026
Chemours USD 1.4B 100M Mar/2026
Corteva USD 4.73B 820M Mar/2026
ICL Group USD 2.02B 320M Mar/2026
Israel Corporation USD 2.02B 170M Mar/2026
PhosAgro RUB 143.18B 4.01B Sep/2025
UPL INR 183.35B 59.74B Mar/2026